Trusted News Discovery Since 2008
{{/content}}
Sun Pharma to acquire remaining stake in subsidiary Taro for $348 million
Credit: IndiaTimes- Published on January 18, 2024
Sun Pharma has announced its intention to acquire the remaining shares of its Israeli subsidiary, Taro Pharma, at a rate of $43 per share, totaling approximately $348 million. This acquisition cost represents 21.52% of Taro's total outstanding shares. Sun Pharma, holding a current stake of about 78.5% in Taro, initially proposed...
You are here
Related videos from verified sources
A Decade of Sun
Credit: Rumble - Published on January 7, 2024